Figure 1.

Changes in disease activity in 30 patients with rheumatoid arthritis at different times during 78 weeks of infliximab therapy as determined by (a) Disease Activity Score (DAS 28) and (b) serum C-reactive protein (CRP) levels. The diamonds indicate median values, vertical bars indicate the interquartile range, and dotted lines indicate the upper normal limit.

Bobbio-Pallavicini et al. Arthritis Res Ther 2004 6:R264-R272   doi:10.1186/ar1173
Download authors' original image